Literature DB >> 4588285

Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

A Kaegi, G F Pineo, A Shimizu, H Trivedi, J Hirsh, M Gent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4588285     DOI: 10.1056/NEJM197402072900604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

Review 2.  The Gordon Wilson lecture: function of blood platelets and their role in thrombosis.

Authors:  J F Mustard
Journal:  Trans Am Clin Climatol Assoc       Date:  1976

Review 3.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

4.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

5.  [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1977-01-15

Review 6.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man.

Authors:  A Eldor; E Zylber-Katz; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Determination of sulfinpyrazone and four metabolites in plasma and urine by high pressure liquid chromatography.

Authors:  E G Lentjes; Y Tan; C A Van Ginneken
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

9.  Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.

Authors:  I D Bradbrook; V A John; P J Morrison; H J Rogers; R G Spector
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

10.  Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.

Authors:  B T Lyman; G J Johnson; J G White
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.